“The Effect of Long-Acting Beta-2 Agonist Monotherapy and Long-Acting Anticholinergic Monotherapy to Quality-of-Life in Group B Stable COPD Patients”, J Respirol Indones, vol. 42, no. 4, pp. 277–281, Sep. 2022, doi: 10.36497/jri.v42i4.370.